Mr. Rastogi became president and CEO of Temple Health in January 2026, after more than 20 years with the health system, most recently as president and CEO of Temple University Hospital and executive vice president and COO of Temple Health. He continues to lead Temple University Hospital while serving as CEO of Temple Health. As president and CEO of Temple University Hospital and its campuses, Mr. Rastogi has guided the institution to national prominence for quality, innovation and clinical excellence, helping make it a destination of choice for complex, specialized care. Under his leadership, the Temple Lung Center became the nation’s highest-volume lung transplant program. Mr. Rastogi has delivered more than $100 million in annual impact through operational and financial improvements and played a pivotal role in the success of two hospital launches. Over his more than two-decade tenure, he has worked across nearly every part of Temple Health, helping advance patient services and clinical infrastructure and expanding the system’s capacity to reinvest in mission-driven priorities.
